國家衛生研究院 NHRI:Item 3990099045/11433
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 882164      線上人數 : 518
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/11433


    題名: Metformin decreases risk of tuberculosis infection in type 2 diabetes patients
    作者: Tseng, CH
    貢獻者: National Institute of Environmental Health Sciences
    摘要: BACKGROUND: Metformin may show an antibiotic effect, but whether its use can reduce the risk of tuberculosis infection has rarely been investigated in population-based studies. METHODS: This is a retrospective cohort analysis of the Taiwan's National Health Insurance database. New-onset type 2 diabetes patients, 148,468 ever users and 15,799 never users of metformin, identified during 1999(-)2005 were followed up until 31 December 2011 for the incidence of tuberculosis infection. Hazard ratios were estimated by Cox regression incorporated with the inverse probability of treatment weighting using propensity score. RESULTS: A total of 360 never users and 1976 ever users developed a tuberculosis infection with respective incidence of 510.91 and 282.94 per 100,000 person(-)years. The overall hazard ratio of presenting a tuberculosis infection among metformin ever users in respect to never users was 0.552 (95% confidence interval: 0.493(-)0.617). The hazard ratios for the first (<27.10 months), second (27.10(-)58.27 months), and third (>58.27 months) tertile of cumulative duration of metformin therapy were 1.116 (0.989(-)1.261), 0.543 (0.478(-)0.618), and 0.200 (0.171(-)0.233), respectively; and were 1.037 (0.918(-)1.173), 0.533 (0.469(-)0.606), and 0.249 (0.215(-)0.288), respectively, for the first (<817,000 mg), second (817,000(-)2,047,180 mg), and third (>2,047,180 mg) tertile of cumulative doses of metformin. The findings were consistent when analyses were restricted to pulmonary tuberculosis. Additionally, regular users of metformin tended to have greater benefit than irregular users. CONCLUSIONS: Metformin use is associated with a reduced risk of tuberculosis infection in a dose(-)response pattern in type 2 diabetes patients.
    日期: 2018-09-09
    關聯: Journal Of Clinical Medicine. 2018 Sep 9;7(9):Article number 264.
    Link to: http://dx.doi.org/10.3390/jcm7090264
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=2077-0383&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000445635800038
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85066888816
    顯示於類別:[其他] 期刊論文

    文件中的檔案:

    檔案 大小格式瀏覽次數
    PUB30205606.pdf755KbAdobe PDF320檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋